Pharmaceutical Preparations
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| Empery Asset Management, LP | 4.00M | $8.0M | 5.02% | -- | 2026-06-30 |
| Rock Springs Capital Management LP | 1.21M | $2.0M | 1.52% | -- | 2026-06-30 |
| DAFNA Capital Management LLC | 1.05M | $2.0M | 1.32% | -- | 2026-06-30 |
| Ghisallo Capital Management LLC | 1.00M | $2.0M | 1.26% | -- | 2026-06-30 |
| ARMISTICE CAPITAL, LLC | 678.0K | $1.0M | 0.85% | -- | 2026-06-30 |
| LMR Partners LLP | 600.0K | $1.0M | 0.75% | -- | 2026-06-30 |
| Stonepine Capital Management, LLC | 571.7K | -- | 0.72% | -- | 2026-06-30 |
| MARSHALL WACE, LLP | 436.0K | -- | 0.55% | +235.6K | 2026-06-30 |
| UBS Group AG | 379.7K | -- | 0.48% | +318.2K | 2026-06-30 |
| JANE STREET GROUP, LLC | 270.8K | -- | 0.34% | -- | 2026-06-30 |
